Published in Cancer Weekly, January 3rd, 2006
"Seladin-1 (from selective Alzheimer disease indicator-1) is a recently discovered gene that has been found to be down-regulated in brain regions affected by Alzheimer disease. Seladin-1 effectively protects neurons against beta-amyloid-mediated toxicity and prevents apoptosis via inhibition of the activation of caspase-3, a key mediator of the apoptotic cascade," wrote P. Luciani and colleagues of the University of Florence.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.